Suppr超能文献

荧光标记如何改变阿尔茨海默病肽的寡聚物大小分布。

How Fluorescent Tags Modify Oligomer Size Distributions of the Alzheimer Peptide.

机构信息

Department of Biotechnology and Biochemistry, Martin-Luther-University Halle-Wittenberg, Halle, Germany.

Department of Physics, Martin-Luther-University Halle-Wittenberg, Halle, Germany.

出版信息

Biophys J. 2019 Jan 22;116(2):227-238. doi: 10.1016/j.bpj.2018.12.010. Epub 2018 Dec 19.

Abstract

Within the complex aggregation process of amyloidogenic peptides into fibrils, early stages of aggregation play a central role and reveal fundamental properties of the underlying mechanism of aggregation. In particular, low-molecular-weight aggregates of the Alzheimer amyloid-β peptide (Aβ) have attracted increasing interest because of their role in cytotoxicity and neuronal apoptosis, typical of aggregation-related diseases. One of the main techniques used to characterize oligomeric stages is fluorescence spectroscopy. To this end, Aβ peptide chains are functionalized with fluorescent tags, often covalently bound to the disordered N-terminus region of the peptide, with the assumption that functionalization and presence of the fluorophore will not modify the process of self-assembly nor the final fibrillar structure. In this investigation, we systematically study the effects of four of the most commonly used fluorophores on the aggregation of Aβ (1-40). Time-resolved and single-molecule fluorescence spectroscopy have been chosen to monitor the oligomer populations at different fibrillation times, and transmission electron microscopy, atomic force microscopy and x-ray diffraction to investigate the structure of mature fibrils. Although the structures of the fibrils were only slightly affected by the fluorescent tags, the sizes of the detected oligomeric species varied significantly depending on the chosen fluorophore. In particular, we relate the presence of high-molecular-weight oligomers of Aβ (1-40) (as found for the fluorophores HiLyte 647 and Atto 655) to net-attractive, hydrophobic fluorophore-peptide interactions, which are weak in the case of HiLyte 488 and Atto 488. The latter leads for Aβ (1-40) to low-molecular-weight oligomers only, which is in contrast to Aβ (1-42). The disease-relevant peptide Aβ (1-42) displays high-molecular-weight oligomers even in the absence of significant attractive fluorophore-peptide interactions. Hence, our findings reveal the potentially high impact of the properties of fluorophores on transient aggregates, which needs to be included in the interpretation of experimental data of oligomers of fluorescently labeled peptides.

摘要

在淀粉样肽的复杂聚集过程中,聚集的早期阶段起着核心作用,并揭示了聚集的基础机制的基本性质。特别是,阿尔茨海默病淀粉样β肽(Aβ)的低分子量聚集体由于其在细胞毒性和神经元凋亡中的作用而引起了越来越多的关注,这是与聚集相关的疾病的典型特征。用于表征低聚物阶段的主要技术之一是荧光光谱法。为此,将 Aβ 肽链用荧光标记物功能化,通常通过共价键结合到肽的无规 N 端区域,假设功能化和荧光团的存在不会改变自组装过程也不会改变最终的纤维状结构。在这项研究中,我们系统地研究了最常用的四种荧光团对 Aβ(1-40)聚集的影响。选择时间分辨和单分子荧光光谱法来监测不同纤维化时间的低聚物群体,并用透射电子显微镜、原子力显微镜和 X 射线衍射来研究成熟纤维的结构。虽然纤维的结构仅受荧光标记物的轻微影响,但检测到的低聚物种类的大小根据所选荧光团而有很大差异。特别是,我们将 Aβ(1-40)(如 HiLyte 647 和 Atto 655 荧光团所发现的)高分子量低聚物的存在与净吸引力、疏水性荧光团-肽相互作用相关,在 HiLyte 488 和 Atto 488 的情况下,这种相互作用很弱。后者导致 Aβ(1-40)仅形成低分子量低聚物,这与 Aβ(1-42)形成对比。与疾病相关的肽 Aβ(1-42)即使在没有明显的吸引力荧光团-肽相互作用的情况下也显示出高分子量低聚物。因此,我们的研究结果揭示了荧光标记肽的瞬态聚集体中荧光团特性的潜在高影响,这需要在解释荧光标记低聚物的实验数据时加以考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/122a/6350010/045b0aaf8dd4/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验